Cerity Partners’s Abiomed Inc ABMD Stock Holding History

Cerity Partners’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,278	Closed	-$315K	–	1541
2022 Q3	$315K	Sell	1,278 -499	-28%	-$135K	﹤0.01%	868
2022 Q2	$440K	Buy	+1,777	New	+$480K	﹤0.01%	781

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cerity Partners's ABMD Position: Q4 2022 in Review

Cerity Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,278 shares — an estimated $315K sold.

Cerity Partners first reported a position in ABMD in Q2 2022 and held it in 2 quarters. The position peaked at $440K in Q2 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Cerity Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Cerity Partners sold 1,278 Abiomed Inc shares in Q4 2022, an estimated $315K.
Cerity Partners first reported a position in Abiomed Inc in Q2 2022 and held it in 2 quarters.
Cerity Partners's Abiomed Inc position peaked at $440K in Q2 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Cerity Partners's 13F filing for Q4 2022, filed 15 Feb 2023.